Intezer offers an AI platform that treats every security alert like a high-priority investigation, using a DNA-style "security genome" to identify origins, permutations and connections among threats. The product automates triage and investigation, claiming to reduce human investigation time from 30–240 minutes to about two minutes. Its stack combines in-house analysis and remediation with third-party technology (including use of OpenAI APIs for natural-language signals) and integrates with vendors such as Palo Alto Networks, Wiz and CrowdStrike. Intezer has a track record of attribution and discovery work (e.g., identifying WannaCry origins and discovering malware families) that underpins its detection models. The company says roughly 4% of an organization’s alerts become escalated red alerts, while overall alert volumes can range from 4,000 to 11,000 per day, which motivates its automation focus. Management plans to expand the business following recent strong growth and the Series C; the company coordinated its fundraise news with a large CrowdStrike user conference. Financially, Intezer raised a $33M Series C and has $60M raised to date; it is based out of New York with deep roots in Israel and is not disclosing valuation. Intezer builds 'genetic malware analysis' software that maps code reuse to identify, track and help eradicate malware. Its core commercial products are Intezer Protect and Intezer Analyze (the latter without remediation). The technology treats binary code like genetic material to uncover the origins of threats and detect code similarities across malware families. Customers include Fortune 500 companies, late-stage startups and elite government agencies. Notable successes cited by the company include identifying WannaCry's North Korean origin, linking the DNC breach to Russian actors, and discovering the Linux-focused HiddenWasp malware family. Led by CEO and co-founder Itai Tevet (formerly of Israel's IDF CERT) alongside co-founders Alon Cohen and Roy Halevi, Intezer plans to use funding to expand customers and apply its model to other binary-code–driven devices such as drones, medical devices and smartphones; the company has raised $25M to date and did not disclose a valuation. Intezer is a cybersecurity startup that applies concepts from the biological immune system to map and identify the "DNA" of every piece of code to detect malware and code reuse. Its core product performs fast code‑DNA mapping to improve malware detection and accelerate incident response. The company has demonstrated success tracing major global threats, including WannaCry, Turla and NotPetya. Intezer is led by co‑founder and CEO Itai Tevet and is based in San Francisco. Financially, Intezer announced an $8 million Series A to support growth. The company plans to use the funding to expand global sales efforts and pursue opportunities in targeted markets. Intezer provides a virtual “security camera” that displays a visual map of all the software running in an organization at any given moment, down to the single code-fragment level in memory. Its platform is aimed at medium to large organizations and is designed to enable security teams to detect and respond to sophisticated cyber attacks regardless of malware behavior or signature. The company was founded in 2015 by Roy Halevi, Itai Tevet and Alon Cohen and is based in Tel Aviv, Israel. On December 16, 2016 Intezer raised $2M in seed funding. The company intends to use the funds to grow its team. The article does not disclose additional operating metrics or revenue figures.

Total raised

$58M

Funding rounds

4

Latest round

Series C

Latest activity

Sep 2024